Thornburg Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Hold
38,400
0.02% 125
2025
Q4
$2.07M Hold
38,400
0.03% 150
2025
Q3
$1.73M Hold
38,400
0.02% 150
2025
Q2
$1.78M Hold
38,400
0.02% 152
2025
Q1
$23.4M Hold
38,400
0.03% 154
2024
Q4
$2.17M Sell
38,400
-30,790
-45% -$1.72M 0.03% 158
2024
Q3
$3.58M Hold
69,190
0.05% 158
2024
Q2
$2.87M Buy
+69,190
New +$3.1M 0.04% 163

Other funds holding BMY

Thornburg Investment Management's BMY Position: Q1 2026 in Review

Thornburg Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 38,400 shares worth $2.33M. The position accounts for 0.02% of the portfolio, ranked #125.

Thornburg Investment Management first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $23.4M in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Thornburg Investment Management held 38,400 shares of Bristol-Myers Squibb worth $2.33M as of Q1 2026.
  • Thornburg Investment Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of Thornburg Investment Management's portfolio in Q1 2026, its #125 holding.
  • Thornburg Investment Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • Thornburg Investment Management's Bristol-Myers Squibb position peaked at $23.4M in Q1 2025.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Thornburg Investment Management's 13F filing for Q1 2026, filed 12 May 2026.